Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 13/20 | 0.64 |
| ▸ | CDK4 | P11802 | 13/20 | 0.64 |
| ▸ | CCND1 | P24385 | 13/20 | 0.64 |
| ▸ | CDK1 | P06493 | 9/20 | 0.64 |
| ▸ | CDK5 | Q00535 | 3/20 | 0.52 |
| ▸ | CDK5R1 | Q15078 | 2/20 | 0.52 |
| ▸ | CDK9 | P50750 | 5/20 | 0.52 |
| ▸ | CDK6 | Q00534 | 5/20 | 0.52 |
| ▸ | CDK11A | Q9UQ88 | 5/20 | 0.52 |
| ▸ | CCNT1 | O60563 | 4/20 | 0.52 |
| ▸ | CCNA2 | P20248 | 4/20 | 0.49 |
| ▸ | CASK | O14936 | 1/20 | 0.47 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.47 |
| ▸ | CDKL5 | O76039 | 1/20 | 0.47 |
| ▸ | STK10 | O94804 | 1/20 | 0.47 |
| ▸ | CDK14 | O94921 | 1/20 | 0.47 |
| ▸ | ABL1 | P00519 | 1/20 | 0.47 |
| ▸ | EGFR | P00533 | 1/20 | 0.47 |
| ▸ | MAK | P20794 | 1/20 | 0.47 |
| ▸ | CDK11B | P21127 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6198732 | 0.94 | CDK4 (0.57) | CDK2CDK4CCND1CDK1CDK5 | |
| SCHEMBL6195586 | 0.94 | CDK4 (0.57) | CDK2CDK4CCND1CDK1CDK5 | |
| SCHEMBL6198310 | 0.92 | CDK5 (0.54) | CDK2CDK4CCND1CDK1CDK5 | |
| SCHEMBL6216994 | 0.90 | CDK4 (0.52) | CDK2CDK4CCND1CDK1CDK5 | |
| SCHEMBL6196763 | 0.90 | CDK4 (0.52) | CDK2CDK4CCND1CDK1CDK5 | |
| SCHEMBL14073871 | 0.89 | CDK2 (0.55) | CDK2CDK4CCND1CDK1CDK5 | |
| SCHEMBL6407196 | 0.89 | CDK4 (0.52) | CDK2CDK4CCND1CDK1CDK5 | |
| SCHEMBL6198789 | 0.89 | CDK2 (0.51) | CDK2CDK4CCND1CDK1CDK5 | |
| SCHEMBL6407347 | 0.89 | CDK4 (0.58) | CDK2CDK4CCND1CDK1CDK5 | |
| SCHEMBL6197032 | 0.88 | CDK4 (0.63) | CDK2CDK4CCND1CDK1CDK5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1771424-B1 | NOVEL 2,4-DIAMINOTHIAZOL-5-ONE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2010-12-15 | — | — | EP | claimed |
| US-7423053-B2 | 4-Aminothiazole derivatives | HOFFMANN-LA ROCHE INC. (US) | 2008-09-09 | — | — | US | claimed |
| EP-1771424-A1 | NOVEL 2,4-DIAMINOTHIAZOL-5-ONE DERIVATIVES | F.HOFFMANN-LA ROCHE AG (CH) | 2007-04-11 | — | — | EP | claimed |
| US-20060014958-A1 | 4-Aminothiazole derivatives | CHEN LI | 2006-01-19 | — | — | US | claimed |
| WO-2006005508-A1 | NOVEL 2,4-DIAMINOTHIAZOL-5-ONE DERIVATIVES | F.HOFFMANN-LA ROCHE AG (CH) | 2006-01-19 | — | — | WO | claimed |
| EP-1771424-B1 | NOVEL 2,4-DIAMINOTHIAZOL-5-ONE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2010-12-15 | — | — | EP | disclosed |
| EP-1771424-B1 | NOVEL 2,4-DIAMINOTHIAZOL-5-ONE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2010-12-15 | — | — | EP | disclosed |
| CN-1976910-B | 2, 4-diaminothiazol-5-one derivatives | HOFFMANN LA ROCHE | 2010-07-21 | — | — | CN | disclosed |
| US-20100002569-A1 | OPTICAL INFORMATION RECORDING MEDIUM, METHOD OF RECORDING AND REPRODUCING INFORMATION, AND AZO METAL COMPLEX DYE | FUJIFILM CORPORATION (JP) | 2010-01-07 | — | — | US | disclosed |
| US-7423053-B2 | 4-Aminothiazole derivatives | HOFFMANN-LA ROCHE INC. (US) | 2008-09-09 | — | — | US | disclosed |
| US-7423053-B2 | 4-Aminothiazole derivatives | HOFFMANN-LA ROCHE INC. (US) | 2008-09-09 | — | — | US | disclosed |
| US-7423053-B2 | 4-Aminothiazole derivatives | HOFFMANN-LA ROCHE INC. (US) | 2008-09-09 | — | — | US | disclosed |
| CN-1976910-A | Novel 2, 4-diaminothiazol-5-one derivatives | HOFFMANN LA ROCHE (CH) | 2007-06-06 | — | — | CN | disclosed |
| EP-1771424-A1 | NOVEL 2,4-DIAMINOTHIAZOL-5-ONE DERIVATIVES | F.HOFFMANN-LA ROCHE AG (CH) | 2007-04-11 | — | — | EP | disclosed |
| US-20060014958-A1 | 4-Aminothiazole derivatives | CHEN LI | 2006-01-19 | — | — | US | disclosed |
| WO-2006005508-A1 | NOVEL 2,4-DIAMINOTHIAZOL-5-ONE DERIVATIVES | F.HOFFMANN-LA ROCHE AG (CH) | 2006-01-19 | — | — | WO | disclosed |
| EP-1597256-A1 | N-HETEROCYCLYL-SUBSTITUTED AMINO-THIAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS | PFIZER INC. (US) | 2005-11-23 | — | — | EP | disclosed |
| US-20050101595-A1 | N-containing cycloalkyl-substituted amino-thiazole derivatives and pharmaceutical compositions for inhibiting cell proliferation and methods for their use | PFIZER INC. | 2005-05-12 | — | — | US | disclosed |
| WO-2004074283-A1 | N-HETEROCYCLYL-SUBSTITUTED AMINO-THIAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS | PFIZER INC. (US) | 2004-09-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060014958-A1 | 4-Aminothiazole derivatives | CDK4, CDK2, CCNI | CDK2 2/4885CDK4 1/4885CCND1 36/4885 |
| US-20050101595-A1 | N-containing cycloalkyl-substituted amino-thiazole derivatives and pharmaceutical compositions for inhibiting cell proliferation and methods for their use | CCNI, MKI67, TK1 | CDK2 6/4885CDK4 78/4885CCND1 61/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.